GeneLink Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2008
2009
2010
2011
2012
Cash & Short Term Investments
435.20
196.90
429.30
740.80
158.50
Total Accounts Receivable
713.60
465.80
305.60
235.50
78.00
Inventories
739.50
494.70
223.70
562.20
393.60
Other Current Assets
53.70
141.40
86.60
320.90
142.30
Total Current Assets
1,942.00
1,298.80
1,045.20
1,859.30
772.30
Net Property, Plant & Equipment
282.00
302.90
256.20
167.80
257.80
Total Investments and Advances
31.10
-
-
-
-
Intangible Assets
290.20
264.40
240.70
618.90
54.90
Other Assets
-
14.70
179.30
133.60
369.80
Total Assets
2,545.20
1,880.80
1,721.30
2,779.70
1,454.80
ST Debt & Current Portion LT Debt
78.30
54.10
-
-
-
Accounts Payable
2,034.30
1,189.70
859.70
1,370.80
989.40
Other Current Liabilities
380.40
483.40
800.10
924.80
849.70
Total Current Liabilities
2,493.00
1,727.20
1,659.80
2,295.60
1,839.10
Long-Term Debt
-
893.40
851.40
965.00
1,089.50
Other Liabilities
-
-
-
1,000.00
1,187.50
Total Liabilities
2,493.00
2,620.60
2,511.10
4,260.70
4,116.20
Common Equity (Total)
52.20
739.80
789.90
1,481.00
2,661.40
Total Shareholders' Equity
52.20
739.80
789.90
1,481.00
2,661.40
Total Equity
52.20
739.80
789.90
1,481.00
2,661.40
Liabilities & Shareholders' Equity
2,545.20
1,880.80
1,721.30
2,779.70
1,454.80

About GeneLink

View Profile
Address
8250 Exchange Drive
Orlando Florida 32809
United States
Employees -
Website http://www.genelinkbio.com
Updated 07/08/2019
GeneLink, Inc. engages in the development of genetics-based assessment products for pharmaceutical applications and DNA storage purpose. It also offers genetically-based nutritional supplements. The company was founded by Robert P.